LUPIN
Back to Income Statement
|
LUPIN Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹22,708 Cr | ₹20,011 Cr | ₹16,642 Cr | ₹16,405 Cr | ₹15,163 Cr |
What is the latest Revenue of LUPIN ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹22,708 Cr |
| Mar2025 | ₹20,011 Cr |
| Mar2024 | ₹16,642 Cr |
| Mar2023 | ₹16,405 Cr |
| Mar2022 | ₹15,163 Cr |
How is Revenue of LUPIN Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹22,708 Cr | 13.48 | |
| Mar2025 | ₹20,011 Cr | 20.25 | |
| Mar2024 | ₹16,642 Cr | 1.44 | |
| Mar2023 | ₹16,405 Cr | 8.19 | |
| Mar2022 | ₹15,163 Cr | - | |
Compare Revenue of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹104,150.2 Cr | -4.5% | -8.8% | 20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -4.5% |
-8.8% |
20.8% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses